课题基金 / 基金详情

2013 Physical Virology Gordon Research Conference and Gordon Research Seminar

2013 Physical Virology Gordon Research Conference and Gordon Research Seminar
2013年物理病毒学戈登研究会议暨戈登研究研讨会
批准号:
8459163
负责人:
Peter E. Prevelige
金额:
$0.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-01-17 至 2013-05-31

项目摘要

项目成果

Peter E. Prevelige的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):物理病毒学戈登研究会议(GRC)的主要目标是促进跨学科的互动和合作,通过克服相关学科之间的传统界限来推动病毒学和纳米医学领域的发展。生物医学研究的突飞猛进往往是将来自不同学科的概念和实验工具应用于共同感兴趣的问题的结果,在这种情况下,病毒和类似病毒的自组装系统的结构、物理性质和用途。虽然物理学家、化学家和生物学家都对这个话题感兴趣,但这些不同领域的科学家很少参加同一次会议。很多时候,一个学科的科学家根本没有意识到限制另一个学科进步的障碍。自2009年成立以来,物理病毒学GRC一直是越来越多的研究人员的焦点会议,他们横跨这些领域,但对病毒的生物、化学和纳米技术以及病毒启发的结构有共同的兴趣。我们的目标是:具体目标1.在GRC聚会的形式下,集合物理病毒学领域的主要研究人员、学生和博士后的杰出计划。NIH的支持对于筹集足够的资金以允许来自遥远地区的同事参加会议至关重要,这是必要的,因为该领域包括来自几个欧洲和亚洲国家的知名科学家。GRC延长的空闲时间为探索合作提供了广阔的机会。例如,将研究人员与病毒学和纳米技术的兴趣结合在一起,已经为创造新的治疗方法和新材料打开了机会。GRC格式鼓励以辩证的方式进行科学讨论。这种对话的先决条件是跨越科学界限交流研究的持续努力。具体目标2.向学生和博士后介绍作为跨学科领域的物理病毒学,以及该领域的主要主要研究人员。GRC之前的戈登-基南研究研讨会将允许学生在一个非恐吓的环境中自由交流思想。为这次会议提供资金的一个具体目标是支持学生和博士后的出席。GRC的时间表已经特别调整,包括海报演讲,以鼓励这些年轻科学家的积极参与。
英文摘要
DESCRIPTION (provided by applicant): The main goal of the Physical Virology Gordon Research Conference (GRC) is to facilitate interdisciplinary interactions and collaborations that will advance the fields of virology and nano-medicine by overcoming traditional boundaries between relevant disciplines. Bursts of progress in biomedical research are often the result of bringing conceptual and experimental tools from various disciplines to bear on a problem of common interest, in this case the structure, physical properties, and utility of viruses and virus-like self-assembled systems. While this topic is of interest to physicists, chemists, and biologist alike, scientists from these diverse fields rarely attend the same meeting. Very often, scientists in one discipline are simply unaware of the barriers limiting progress in another. From its inception in 2009, the Physical Virology GRC has been a focal meeting for a growing community of researchers that span these fields, but have common interests in the biology, chemistry, and nanotechnology of viruses and virus-inspired structures. Our goals are as follows. Specific Aim 1. Assemble an outstanding program of leading investigators, students, and postdocs in the field of physical virology, under the format of GRC gatherings. NIH support is essential to raising sufficient funds to allow colleagues from distant locations to attend the conference, necessary because the field includes prominent scientists from several European and Asian countries. The extended free time at the GRC provides a broad opportunity to explore collaboration. For example, mixing researchers with interests in virology and nanotechnology has already opened opportunities to generate new therapeutic approaches and new materials. The GRC format encourages a dialectic approach to scientific talks. The prerequisite for such a dialog is a sustained effort to communicate research across scientific boundaries. Specific Aim 2. Introduce students and postdocs to physical virology as an interdisciplinary field, and to the key principal investigators in the field. The Gordon-Keenan Research seminar preceding the GRC will allow students to freely exchange ideas in a non-intimidating environment. A specific goal of funding for this meeting is to support attendance of students and postdocs. The GRC schedule has been specifically adapted to include poster talks to encourage active participation of these young scientists.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CRYOEM OF PHI29 CONNECTOR/SCAFFOLDING COMPLEXES
  • 批准号:
    8362465
  • 项目类别:
  • 资助金额:
    $0.64万
  • 财政年份:
    2011
  • 负责人:
    Peter E. Prevelige
  • 依托单位:
CRYOEM OF PHI29 CONNECTOR/SCAFFOLDING COMPLEXES
  • 批准号:
    8169686
  • 项目类别:
  • 资助金额:
    $1.29万
  • 财政年份:
    2010
  • 负责人:
    Peter E. Prevelige
  • 依托单位:
THE EFFECTS OF DOMAIN SWAPPING IN HIV-1 CAPSID PROTEIN
  • 批准号:
    8168736
  • 项目类别:
  • 资助金额:
    $0.93万
  • 财政年份:
    2010
  • 负责人:
    Peter E. Prevelige
  • 依托单位:
THE EFFECTS OF DOMAIN SWAPPING IN HIV-1 CAPSID PROTEIN
  • 批准号:
    7953972
  • 项目类别:
  • 资助金额:
    $0.01万
  • 财政年份:
    2009
  • 负责人:
    Peter E. Prevelige
  • 依托单位:
海外基金